3B Blackbio Dx Profile
Key Indicators
- Authorised Capital ₹ 16.20 Cr
as on 15-07-2024
- Paid Up Capital ₹ 8.58 Cr
as on 15-07-2024
- Company Age 52 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 12.72 Cr
as on 15-07-2024
- Satisfied Charges ₹ 4.88 Cr
as on 15-07-2024
- Revenue -37.21%
(FY 2023)
- Profit -73.03%
(FY 2023)
- Ebitda 24.29%
(FY 2023)
- Net Worth 1.21%
(FY 2023)
- Total Assets -5.52%
(FY 2023)
About 3B Blackbio Dx
It is listed on the Bombay Stock Exchange(BSE) under the ticker symbol 532067.
The Corporate was formerly known as Kilpest Private Limited. The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 16.20 Cr and a paid-up capital of Rs 8.58 Cr.
The company currently has active open charges totaling ₹12.72 Cr. The company has closed loans amounting to ₹4.88 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at 3B Blackbio Dx Limited India are Nikhil Dubey as CFO and Navneet Kaur as Company Secretary. Nikhil Dubey, Dhirendra Dubey, Shabbar Husain, and Three other members serve as directors at the Company.
- CIN/LLPIN
L24211MP1972PLC001131
- Company No.
001131
- Stock Symbol
BSE : 532067
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
27 May 1972
- Date of AGM
22 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Listed
- ROC Code
Roc Gwalior
Industry
Company Details
- Location
Bhopal, Madhya Pradesh, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does 3B Blackbio Dx Limited offer?
3B Blackbio Dx Limited offers a wide range of products and services, including Medical Laboratory Instruments, Corona Test Kit, Rapid Test Kit, RT PCR Test Kit.
Who are the key members and board of directors at 3B Blackbio Dx?
Executive Team (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Dhirendra Dubey  | Managing Director | 01-Jul-1995 | Current |
| Nikhil Dubey | CFO | 23-May-2018 | Current |
| Navneet Kaur | Company Secretary | 11-Jan-2016 | Current |
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Nikhil Dubey | Whole-Time Director and Cfo | 11-Aug-1993 | Current |
| Shabbar Husain | Director | 28-Mar-2003 | Current |
| Mithla Dubey | Director | 27-Mar-2015 | Current |
| Abdul Khan | Director | 25-Sep-2017 | Current |
| Harihar Thapak | Director | 23-Sep-2022 | Current |
Financial Performance of 3B Blackbio Dx.
3B Blackbio Dx Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 37.21% decrease. The company also saw a substantial fall in profitability, with a 73.03% decrease in profit. The company's net worth moved up by a moderate rise of 1.21%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of 3B Blackbio Dx?
In 2022, 3B Blackbio Dx had a promoter holding of 38.43% and a public holding of 61.57%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Mithala Laboratoreis Pvt LtdActive 44 years 3 monthsNikhil Dubey and Mithla Dubey are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 27 Jun 2011 | ₹2.50 M | Open |
20 Th Centuray Finance Corp. Ltd. Creation Date: 05 Sep 1995 | ₹1.70 M | Open |
State Bank Of India Creation Date: 31 Mar 1992 | ₹12.30 Cr | Open |
How Many Employees Work at 3B Blackbio Dx?
3B Blackbio Dx has a workforce of 78 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of 3B Blackbio Dx, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped 3B Blackbio Dx's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
